A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands

Background Actinic keratosis (AK) is a common premalignant skin condition that might have the ability to progress into squamous cell carcinoma. Due to the high incidence of AK, treatment of this disease significantly impacts healthcare spending. Objectives To determine which commonly prescribed field-directed treatment is the most cost-effective, when comparing 5-fluorouracil (5-FU) 5%, imiquimod (IMQ) 5%, ingenol mebutate (IM) 0 center dot 015% and methyl aminolaevulinate photodynamic therapy (MAL-PDT) for AK in the head and neck region. Methods We performed an economic evaluation from a heal... Mehr ...

Verfasser: Jansen, M. H. E.
Kessels, J. P. H. M.
Merks, I.
Nelemans, P. J.
Kelleners-Smeets, N. W. J.
Mosterd, K.
Essers, B. A. B.
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: Jansen , M H E , Kessels , J P H M , Merks , I , Nelemans , P J , Kelleners-Smeets , N W J , Mosterd , K & Essers , B A B 2020 , ' A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands ' , British Journal of Dermatology , vol. 183 , no. 4 , pp. 738-744 . https://doi.org/10.1111/bjd.18884
Schlagwörter: ECONOMIC-EVALUATION / SOLAR KERATOSES / FIELD
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26821734
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/8b6fb3c2-5675-48a1-9d5e-84b02dd68e87